Sunday, January 25, 2009

MS and Medical Marijuana

By Dr. Julian Reindhurst

Dealing with tight, sore, contracting muscles is life for many of the 2.5 million people around the planet suffer from Multiple Sclerosis. Such is the case for many of the 15 million patients with spinal cord injuries who also suffer from the same symptoms, which cause pain, limit movement, and rob people of needed sleep.

Several conventional medications are available to help mitigate some of the discomfort, yet they rarely provide the patient with total relief. These conventional drugs often times cause weakness, make the patient constantly sleepy, and has side effects that many of the patients find intolerable such as constant constipation.

With an outlook such as this, many patients with both spinal chord injuries and MS have sought out medical marijuana because of the complete decrease in pain.

Patients also stated that the plant assisted with their nausea and helped them sleep better. A survey given to people with spinal chord injuries in 1982 found that 21 of the 43 patients said that marijuana mitigated their pain, while a similar survey in 1997 found that out of the 112 surveyed stated that the drug lessened both the spasticity (when the muscles tense reflexively and resist stretching) and pain.

This case study is not intended to prove that all people who suffer from MS find marijuana useful, but those that use marijuana do.

Animal research demonstrates that marijuana reduces muscle spasticity. Spasms are theorized to occur in areas of the brain that manage movement, including various areas that have abundant cannabinoid receptors.

In one experiment, researchers found that rodents became more animated under the influence of small amounts of cannabinoids but less active when they received larger doses.

Users also state that the drug affects their movement by making their body's sway back and fourth.

It's still unknown how the compounds of the cannabinoids create this effect. With all of the findings that suggest the plant has anecdotal properties, clinical research remains largely untested.

Very few reports are helpful because they are limited in the amount of people and in general hard to find.

There is a lack of good universally medication available for muscle spasticity so it makes a very compelling argument in research cannonaded compounds. - 20896

About the Author:

No comments:

Post a Comment